FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Read more
Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer Read more
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD Read more
Iktos Announces Collaboration with Merck for Use of Iktos AI Technology across Three Drug Discovery Projects Read more
EC approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors Read more
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca Read more
FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin 1 Read more
Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies Read more